Cargando…

Use of T Cell Mediated Immune Functional Assays for Adjustment of Immunosuppressive or Anti-infective Agents in Solid Organ Transplant Recipients: A Systematic Review

Background: Defining the optimal dosage of the immunosuppressive or duration of anti-infective agents is a challenge in solid organ transplant (SOT) recipients. We aimed to systematically review the literature regarding the use of T cell mediated immune functional assays (IFAs) for adjustment of the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rezahosseini, Omid, Møller, Dina Leth, Knudsen, Andreas Dehlbæk, Sørensen, Søren Schwartz, Perch, Michael, Gustafsson, Finn, Rasmussen, Allan, Ostrowski, Sisse Rye, Nielsen, Susanne Dam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7593245/ https://www.ncbi.nlm.nih.gov/pubmed/33178194 http://dx.doi.org/10.3389/fimmu.2020.567715

Ejemplares similares

Bacterial and fungal bloodstream infections in pediatric liver and kidney transplant recipients
por: Møller, Dina Leth, et al.
Publicado: (2021)

An Observational Prospective Cohort Study of Incidence and Outcome of Streptococcus pneumoniae and Hemophilus influenzae Infections in Adult Solid Organ Transplant Recipients
por: Rezahosseini, Omid, et al.
Publicado: (2021)

Prediction of herpes virus infections after solid organ transplantation: a prospective study of immune function
por: Møller, Dina Leth, et al.
Publicado: (2023)

Immune function as predictor of infectious complications and clinical outcome in patients undergoing solid organ transplantation (the ImmuneMo:SOT study): a prospective non-interventional observational trial
por: Drabe, Camilla Heldbjerg, et al.
Publicado: (2019)

Influenza in Liver and Kidney Transplant Recipients: Incidence and Outcomes
por: Arentoft, Nicoline Stender, et al.
Publicado: (2023)

Incidence and severity of SARS-CoV-2 infections in liver and kidney transplant recipients in the post-vaccination era: Real-life data from Denmark
por: Hamm, Sebastian Rask, et al.
Publicado: (2022)

Decline in Antibody Concentration 6 Months After Two Doses of SARS-CoV-2 BNT162b2 Vaccine in Solid Organ Transplant Recipients and Healthy Controls
por: Hamm, Sebastian Rask, et al.
Publicado: (2022)

Humoral and T-cell response 12 months after the first BNT162b2 vaccination in solid organ transplant recipients and controls: Kinetics, associated factors, and role of SARS-CoV-2 infection
por: Rezahosseini, Omid, et al.
Publicado: (2023)

Effect of influenza vaccination in solid organ transplant recipients: A nationwide population‐based cohort study
por: Harboe, Zitta Barrella, et al.
Publicado: (2022)

The Induced Immune Response in Patients With Infectious Spondylodiscitis: A Prospective Observational Cohort Study
por: Loft, Josefine Amalie, et al.
Publicado: (2022)

Clostridium difficile Infection in Solid Organ and Haematopoietic Stem Cell Transplant Recipients
por: Ilett, Emma Elizabeth, et al.
Publicado: (2017)

Improved induced innate immune response after cART initiation in people with HIV
por: Hove-Skovsgaard, Malene, et al.
Publicado: (2022)

Achromobacter spp. in a Cohort of Non-Selected Pre- and Post-Lung Transplant Recipients
por: Crone, Cornelia Geisler, et al.
Publicado: (2022)

1597. Risk Factors for Failure of Primary (Val)ganciclovir Prophylaxis Against Cytomegalovirus (CMV) Infection and Disease in Solid Organ Transplant (SOT) Recipients
por: Khurana, Mark Poulsen, et al.
Publicado: (2018)

Impact of CMV Blips in Transplant Recipients
por: Lodding, Isabelle Paula, et al.
Publicado: (2017)

Torque-Teno virus to optimize timing of vaccination against severe acute respiratory syndrome coronavirus 2 in solid organ transplant recipients
por: Rezahosseini, Omid, et al.
Publicado: (2021)

Risk Factors for Failure of Primary (Val)ganciclovir Prophylaxis Against Cytomegalovirus Infection and Disease in Solid Organ Transplant Recipients
por: Khurana, Mark P, et al.
Publicado: (2019)

23. Development and Validation of a Risk Score for Post-transplant Lymphoproliferative Disorders among Solid Organ Transplant Recipients
por: dos Santos, Quenia, et al.
Publicado: (2021)

Pneumocystis jirovecii pneumonia in liver transplant recipients in an era of routine prophylaxis
por: Andreasen, Philip B., et al.
Publicado: (2021)

Development and Validation of a Risk Score for Post-Transplant Lymphoproliferative Disorders among Solid Organ Transplant Recipients
por: dos Santos, Quenia, et al.
Publicado: (2022)

Early‐ and late‐onset posttransplant lymphoproliferative disorders among adult kidney and liver transplant recipients
por: Abdulovski, Ranya, et al.
Publicado: (2022)

1584. Development and Dynamics of Cytomegalovirus UL97 Ganciclovir Resistance Mutations in Transplant Recipients Detected by Next-generation Sequencing
por: Lodding, Isabelle Paula, et al.
Publicado: (2018)

Identification of two different coagulation phenotypes in people living with HIV with undetectable viral replication
por: Fink, Asbjørn, et al.
Publicado: (2021)

1079. The Risk of Cytomegalovirus (CMV) Infection and Recurrence Among Solid Organ Transplant Recipients
por: Reekie, Joanne, et al.
Publicado: (2020)

Impact of CMV PCR Blips in Recipients of Solid Organ and Hematopoietic Stem Cell Transplantation
por: Lodding, Isabelle P., et al.
Publicado: (2018)

Development and Dynamics of Cytomegalovirus UL97 Ganciclovir Resistance Mutations in Transplant Recipients Detected by Next-Generation Sequencing
por: Lodding, Isabelle P, et al.
Publicado: (2021)

Incidence Rates and Risk Factors of Clostridioides difficile Infection in Solid Organ and Hematopoietic Stem Cell Transplant Recipients
por: Ilett, Emma E, et al.
Publicado: (2019)

Aortic aneurysms and markers of platelet activation, hemostasis, and endothelial disruption in people living with HIV
por: Grønbæk, Sylvester Klöcker, et al.
Publicado: (2023)

Posttransplantation Diabetes Mellitus Among Solid Organ Recipients in a Danish Cohort
por: Dos Santos, Quenia, et al.
Publicado: (2022)

Trends in underlying causes of death in solid organ transplant recipients between 2010 and 2020: Using the CLASS method for determining specific causes of death
por: Søborg, Andreas, et al.
Publicado: (2022)

Prognostic value of suPAR and hsCRP on acute kidney injury after cardiac surgery
por: Rasmussen, Sebastian Roed, et al.
Publicado: (2021)

Recovery of Moderate Coronavirus Disease 2019 in a Liver Transplant Recipient on Continued Immunosuppression: A Case Report
por: Mathiasen, Victor Dahl, et al.
Publicado: (2020)

Humoral and cellular immune responses eleven months after the third dose of BNT162b2 an mRNA-based COVID-19 vaccine in people with HIV – a prospective observational cohort study
por: Heftdal, Line Dam, et al.
Publicado: (2023)

Risk-Adjusted Impact of Administrative Costs on the Distribution of Terminal Wealth for Long-Term Investment
por: Guillén, Montserrat, et al.
Publicado: (2014)

Risk Factors for Being Seronegative following SARS-CoV-2 Infection in a Large Cohort of Health Care Workers in Denmark
por: Johannesen, Caroline Klint, et al.
Publicado: (2021)

The Danish comorbidity in liver transplant recipients study (DACOLT): a non-interventional prospective observational cohort study
por: Thomsen, Magda Teresa, et al.
Publicado: (2021)

Immunosuppressant Adherence Factors Differentiating Compliant and Non-Compliant Kidney Transplant Recipients
por: Ostrowski, Piotr, et al.
Publicado: (2023)

Cytomegalovirus (CMV) Disease Despite Weekly Preemptive CMV Strategy for Recipients of Solid Organ and Hematopoietic Stem Cell Transplantation
por: Lodding, I P, et al.
Publicado: (2018)

Previous immunity shapes immune responses to SARS-CoV-2 booster vaccination and Omicron breakthrough infection risk
por: Pérez-Alós, Laura, et al.
Publicado: (2023)

Tuberculosis among Patients Undergoing Solid Organ Transplantation or Dialysis in a Low-Endemic Country, 2004-2017
por: Helleberg, Marie, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ptcaqlh38f047e09v7rk44ocd8